Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
PUT
VanEck Junior Gold Miners ETF
GDXJ
$8.54B
| $66.3M | 0.02% |
582,500
+557,500
| +2,230% | +$57.6M |
|
652
CALL
Sea Limited
SE
$70.3B
| $66.1M | 0.02% |
518,500
+251,000
| +94% | +$37.2M |
|
653
Kimco Realty
KIM
$16.2B
| $66.1M | 0.02% |
3,259,451
+73,547
| +2% | +$1.53M |
|
654
American Water Works
AWK
$26.9B
| $65.9M | 0.02% |
505,192
+125,892
| +33% | +$16.8M |
|
655
PUT
Walt Disney
DIS
$178B
| $65.8M | 0.02% |
578,300
-175,000
| -23% | -$19.3M |
|
656
PUT
Pfizer
PFE
$154B
| $65.6M | 0.02% |
2,635,400
+2,350,300
| +824% | +$59.3M |
|
657
Aptiv
APTV
$10.3B
| $65.1M | 0.02% |
855,158
-3,652
| -0.4% | -$293K |
|
658
Lennar Class A
LEN
$20.6B
| $64.8M | 0.02% |
630,458
-108,534
| -15% | -$13.1M |
|
659
Entergy
ETR
$49.3B
| $64.6M | 0.02% |
698,899
-148,409
| -18% | -$14.1M |
|
|
SCHW
660
PUT
Charles Schwab
SCHW
$187B
| $64.3M | 0.02% |
643,600
| – | – |
|
661
Insulet
PODD
$9.91B
| $64.2M | 0.02% |
225,889
+32,689
| +17% | +$10.2M |
|
662
PUT
AB InBev
BUD
$164B
| $64.1M | 0.02% |
1,001,000
| – | – |
|
663
Performance Food Group
PFGC
$17.9B
| $64.1M | 0.02% |
712,653
-558,530
| -44% | -$53.9M |
|
664
CALL
Freeport-McMoran
FCX
$98.7B
| $64M | 0.02% |
1,259,200
+362,700
| +40% | +$15.7M |
|
665
PUT
Floor & Decor
FND
$6.3B
| $63.9M | 0.02% |
1,050,000
-1,816,100
| -63% | -$118M |
|
666
State Street SPDR S&P Homebuilders ETF
XHB
$1.58B
| $63.7M | 0.02% |
618,589
-253,200
| -29% | -$26.9M |
|
667
iShares Core S&P 500 ETF
IVV
$904B
| $63.6M | 0.02% |
92,894
-58,935
| -39% | -$40M |
|
|
668
CALL
Walt Disney
DIS
$178B
| $63.6M | 0.02% |
558,800
| – | – |
|
669
CALL
AbbVie
ABBV
$438B
| $63.4M | 0.02% |
277,300
-8,800
| -3% | -$2M |
|
670
PUT
Wayfair
W
$14.1B
| $63.3M | 0.02% |
630,000
+59,500
| +10% | +$5.72M |
|
671
Dover
DOV
$28.3B
| $63.1M | 0.02% |
323,205
-85,475
| -21% | -$15.6M |
|
672
Comfort Systems
FIX
$58.9B
| $63.1M | 0.02% |
67,583
+2,879
| +4% | +$2.66M |
|
673
WEC Energy
WEC
$34.6B
| $63M | 0.02% |
597,288
-98,302
| -14% | -$10.9M |
|
674
CALL
Netflix
NFLX
$318B
| $62.9M | 0.02% |
670,400
+213,400
| +47% | +$23M |
|
675
Five Below
FIVE
$13B
| $62.8M | 0.02% |
333,607
-116,195
| -26% | -$18.9M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.